CT Angiography Analysis
CT angiography models segment arterial anatomy and compute diameters and lengths, producing measurements the surgeon verifies before they inform any planning discussion.
AI vascular surgery software applies machine learning to CT angiography, duplex ultrasound, and surveillance records to support vascular teams with measurement, surveillance tracking, and screening prompts. It functions as decision support only: the vascular surgeon interprets every study and makes all diagnostic and operative decisions.
Vascular care depends on measuring change over years, since aneurysm surveillance and peripheral disease progression are both longitudinal problems. Taction Software builds AI vascular surgery tooling that structures measurement and surveillance data so change becomes trackable, keeping interpretation with the treating surgeon throughout.

Our experts are ready to understand your business goals.






























































AI vascular surgery software refers to machine learning and workflow automation applied to vascular care: CT angiography segmentation and measurement, aneurysm surveillance tracking, peripheral arterial disease screening support, duplex ultrasound data structuring, endovascular planning, and registry reporting. Models segment vessels, measure diameters, and flag surveillance intervals coming due. Where the work is catheter-based intervention specifically, our interventional radiology practice overlaps considerably. Every measurement is verified and every decision made by the surgeon. This work sits inside our broader healthcare AI practice.
CT angiography models segment arterial anatomy and compute diameters and lengths, producing measurements the surgeon verifies before they inform any planning discussion.
AAA surveillance tooling tracks maximum diameter across serial imaging and flags intervals coming due, addressing follow-up loss that surveillance programs struggle with.
PAD screening support organizes ABI, symptom, and risk data into a referral prompt for clinician review, without producing any diagnosis independently.
Vascular lab tooling structures duplex velocities and stenosis grading into records, making serial comparison practical rather than dependent on report review.
Planning tooling organizes measurements and prior imaging for endovascular case preparation, with device selection and technique determined entirely by the surgeon.
Every output carries clinical decision support framing. The software does not diagnose, determine repair thresholds, or make operative decisions in any configuration we build.
Our AI vascular surgery services cover imaging integration, measurement modeling, surveillance program tooling, vascular lab systems, and registry reporting. Vascular programs sit across imaging, the noninvasive lab, the operating room, and outpatient surveillance, which means the integration surface is wide. Surveillance follow-up is also a recognized weakness in most programs, where patients are lost between imaging intervals. Engagements typically open with a review of imaging archives, vascular lab systems, and current surveillance tracking practice. Deliverables are structured so surgeons, lab technologists, and registry staff can review independently.
We build DICOM pipelines for CTA and MRA volumes with segmentation models, integrating results into archives and viewers rather than a separate application.
We develop vessel measurement models with documented provenance, holdout evaluation, and reproducibility testing, since surveillance decisions depend on measurement consistency over years.
Surveillance tooling tracks intervals, flags overdue studies, and manages recall, addressing follow-up loss that undermines otherwise well-run aneurysm programs.
Lab tooling structures duplex data and reporting, drawing on our radiology information system development work for reporting integration patterns.
Structured extraction prepares vascular registry submissions from clinical data, reducing manual abstraction while keeping staff verification required before filing.
Multi-site programs need remote review, drawing on our teleradiology platform work for asynchronous review workflow.
The benefits of AI vascular surgery software concentrate in measurement reproducibility, surveillance reliability, and reduced abstraction burden. Aneurysm diameter measured manually varies between readers and between studies, which matters directly when a threshold governs intervention timing. Surveillance follow-up loss is a well-recognized program weakness that systematic tracking addresses. We publish no figures on rupture rates, intervention timing, or outcomes, because those depend entirely on patient population and clinical practice. What we deliver is instrumentation so your program measures against its own data.
Automated measurement reduces inter-reader variability in diameter assessment, producing values that compare reliably across studies where thresholds govern decisions.
Systematic interval tracking and recall reduce surveillance loss, addressing a gap where patients disappear between imaging studies years apart.
Structured screening data supports timely referral for peripheral disease, complementing AI wound care assessment workflows on the limb preservation side.
Consolidated measurements and prior imaging reduce planning time before endovascular cases, with the surgeon making every device and technique decision.
Structured extraction lowers registry abstraction workload, freeing staff time in programs managing multiple national registry submissions.
Vascular and cardiac care frequently overlap, connecting with cardiology AI workflows for shared risk patient populations.
We deliver AI vascular surgery projects in gated phases so clinical stakeholders approve direction before engineering cost accumulates. Discovery establishes intended use, imaging data availability, and regulatory classification, since measurement output informing repair decisions may carry Software as a Medical Device obligations. Development is iterative with surgeon review inside each cycle. For measurement models we place particular weight on reproducibility testing, because a model that measures consistently but slightly differently than your prior manual method will disrupt surveillance trends unless that shift is characterized.
Discovery defines intended use, evaluates archive condition, and assesses whether SaMD classification applies, producing a fixed-scope estimate and architecture plan.
We assemble de-identified imaging sets and annotation protocols, measuring agreement, since ground truth quality constrains measurement model performance directly.
Development emphasizes measurement reproducibility alongside accuracy, characterizing any systematic offset from your prior method so surveillance trends stay interpretable.
Integration delivers results into archives, viewers, and reporting, tested against your PACS configuration rather than assuming standards conformance.
Measurement support runs in shadow deployment first, logging output alongside reader measurements so your team quantifies agreement before clinical display.
Rollout expands with performance dashboards, clinical review, and continuing post-deployment surveillance for the life of the deployment.
Vascular software handles PHI and large imaging volumes, with CTA studies accumulating substantial storage across surveillance programs spanning years. Taction holds ISO 27001 certification and follows HIPAA-aligned engineering practice. Where measurement output informs repair threshold decisions, SaMD classification may apply, and this is a case where the clinical stakes make classification worth resolving early rather than assuming research use. Long-term reproducibility is also a compliance-adjacent concern, since a model update that shifts measurement systematically can distort surveillance trends already in progress.
Builds apply encryption in transit and at rest, role-based access, and complete audit logging. Our HIPAA compliance software development practice defines these controls.
Measurement informing repair decisions may trigger SaMD classification. Our FDA SaMD compliance services cover design history, validation, and change control.
Model versioning is critical here, since a measurement shift between versions can distort active surveillance trends. Prior measurements remain attributable to their producing version.
We implement DICOM services and Structured Reporting, with tiered imaging retention designed deliberately given surveillance archives spanning many years.
Validation reports performance by scanner, contrast protocol, vessel segment, and patient subgroup, with continuing bias monitoring across populations.
Deployments run on-premise, in your cloud tenancy, or hybrid, with network segmentation, signed container images, and documented penetration testing before release.
Taction Software was founded in 2013 and has spent over 12 years building healthcare software, delivering more than 200 healthcare projects from four US offices in Chicago, Cheyenne, Austin, and Sacramento, with ISO 27001 certification. Our relevant strength here is imaging pipeline engineering plus disciplined version control, which matters more in vascular surveillance than in most imaging work because measurements are compared across years and model changes have consequences. Our leadership brings more than 20 years of personal experience in the field.
We build DICOM pipelines, segmentation integration, and archive write-back, which is the practical bulk of vascular imaging AI work beyond model training.
We treat model versioning and measurement traceability as first-class requirements, which surveillance programs comparing values across years genuinely depend on.
Founded in 2013, we have concentrated on healthcare rather than treating it as one vertical among several, producing depth in clinical workflow and imaging systems.
We delivered the FDA-registered applications Revive Ease and PainKare, so design controls and validation documentation are established practice rather than unfamiliar territory.
We build clinical decision support with clinician interpretation preserved, detailed in our clinical decision support software development practice.
ISO 27001 certification and HIPAA-aligned engineering mean security controls are documented and auditable, supporting your vendor risk assessment efficiently.
AI vascular surgery pricing depends on scope, imaging data condition, integration surface, and regulatory pathway. A surveillance tracking module reading existing report data costs considerably less than custom CTA segmentation models requiring annotation, reproducibility testing, and a regulatory submission. We price after discovery, because archive condition and scanner heterogeneity drive a large share of effort. Discovery produces an itemized, fixed-scope estimate with phase-level breakdown so components can be approved or deferred. Cloud infrastructure, third-party model licensing, and archive interface fees are separate from engineering and itemized clearly.
An MVP covering surveillance interval tracking and recall typically runs $40,000 to $80,000, addressing follow-up loss before broader imaging work begins.
A full platform with segmentation, measurement, surveillance, lab integration, and registry reporting typically falls between $80,000 and $200,000 depending on validation depth.
Enterprise engagements covering multi-site rollout, custom model development, external validation, and regulatory documentation start at $200,000 and scale with site count.
Discovery is a paid, time-boxed phase producing an itemized estimate, architecture plan, and regulatory assessment. It is deliberately separable so you can evaluate our work first.
Annotation volume, reproducibility testing depth, scanner heterogeneity, and SaMD documentation are the largest variables, each identified during discovery for realistic budget planning.
Post-launch model revalidation, version management, storage growth, and support are quoted separately as a retainer sized to your surveillance volume.
If you are evaluating AI vascular surgery tooling for CTA measurement, aneurysm surveillance tracking, PAD screening support, or registry reporting, the fastest next step is a discovery call with our clinical engineering team. We will review your archives, surveillance practice, and intended use, then return an itemized, fixed-scope estimate with a clear regulatory assessment. Contact us to schedule that conversation.
Vascular programs evaluating AI vascular surgery software typically ask about measurement reliability across years, whether output influences repair decisions, and how surveillance follow-up is improved. The answers below reflect how we scope these projects. If your program spans multiple sites with different scanners or includes an office-based lab, the specifics matter more than any general answer.
Not necessarily, and that matters. Automated measurement is often more reproducible but may carry a systematic offset from manual technique. We characterize that offset during validation so your team knows how to interpret trends spanning both methods, rather than discovering a discontinuity mid-surveillance.
No. It produces measurements and flags surveillance intervals, and the vascular surgeon interprets every study and makes all decisions about intervention timing and technique. The software does not apply thresholds, recommend repair, or make operative determinations in any configuration we build.
Through systematic interval tracking, overdue flagging, and recall workflow, since follow-up loss in aneurysm surveillance is usually an administrative failure rather than a clinical one. Patients scheduled years out fall off manual tracking, and structured recall addresses that directly without changing clinical criteria.
An MVP or single module runs $40,000 to $80,000. A full platform typically falls between $80,000 and $200,000. Enterprise deployments with multi-site rollout and custom models start at $200,000. Discovery produces an itemized, fixed-scope estimate, with storage and licensing quoted separately from engineering.
Version changes are controlled and documented, with prior measurements permanently attributable to the version that produced them. Where an update shifts measurement, we characterize and communicate the shift before deployment, because silently changing measurement inside an active surveillance program is unacceptable.
Usually yes, through standards-based interfaces where the lab system supports them and vendor-specific adapters where it does not. Duplex reporting systems vary considerably in export capability, so we verify what your specific configuration permits during discovery rather than assuming access.
Your email address will not be published. Required fields are marked *
Our expert reaches out shortly after receiving your request and analyzing your requirements.
If needed, we sign an NDA to protect your privacy.
We request additional information to better understand and analyze your project.
We schedule a call to discuss your project, goals. and priorities, and provide preliminary feedback.
If you're satisfied, we finalize the agreement and start your project.